Diseases, Conditions, Syndromes

COVID-19: German scientists lay basis for a passive vaccination

Researchers at the German Center for Neurodegenerative Diseases (DZNE) and Charité - Universitätsmedizin Berlin have identified highly effective antibodies against the coronavirus SARS-CoV-2 and are now pursuing the development ...

Pediatrics

It's time to include children in COVID-19 vaccine trials

When it comes to COVID-19 vaccine development, don't leave kids behind. This is the message from Sharon Nachman, MD, chief of the Division of Pediatric Infectious Diseases at Stony Brook Children's Hospital, and her co-authors ...

Diseases, Conditions, Syndromes

For an effective COVID vaccine, look beyond antibodies to T-cells

More than 100 companies have rushed into vaccine development against COVID-19 as the U.S. government pushes for a vaccine rollout at "warp speed"—possibly by the end of the year—but the bar set for an effective, long-lasting ...

Vaccination

Ethics must not be ignored when testing COVID-19 vaccines

The grassroots organization 1Day Sooner has been asking people to indicate their willingness to volunteer for human challenge studies of COVID-19. Challenge studies, in which healthy people are intentionally exposed to infection, ...

Medical research

A nanomaterial path forward for COVID-19 vaccine development

From mRNA vaccines entering clinical trials, to peptide-based vaccines and using molecular farming to scale vaccine production, the COVID-19 pandemic is pushing new and emerging nanotechnologies into the frontlines and the ...

Diseases, Conditions, Syndromes

Q&A: Getting to a COVID-19 vaccine as fast and as safely as possible

The novel coronavirus is not expected to disappear anytime soon. With physical distancing, virus testing, contact tracing, and potentially new therapeutics, we may be able to keep it partially at bay. But many eyes are looking ...

page 17 from 35